Sub menu

 

 

CSL Behring (Australia) Pty Ltd

Regulatory activities for this sponsor.

Type

Date

Filters applied:Clear all
1 result(s) found, displaying 1 to 1

  • Hemgenix (etranacogene dezaparvovec)

    Prescription medicine decision summary
    Hemgenix (etranacogene dezaparvovec) has been approved for the treatment of adults with haemophilia B (congenital factor IX deficiency).